The haptoglobin (Hp) 2-2 gene is dysfunctional in people with diabetes and increases their risk of cardiovascular disease. Researchers at Technion-Israel Institute of Technology, Haifa, Israel, tested the antioxidant vitamin E to protect diabetic patients with HP 2-2 from cardiovascular complications.